We met Rob Lester who told us about his experience of being treated for advanced prostate cancer with abiraterone - a drug discovered by the ICR.
Our latest research shows that within the next decade, we can make acute lymphoblastic leukaemia (ALL) preventable. Your support will help us make this disease a thing of the past.
Professor Clare Isacke reveals she will be co-chairing the anniversary NCRI conference in 2019.
First-year PhD student, Anabel Zelceski, offers her thoughts on studying at a world-leading cancer research organisation.
Professor Clare Isacke told us what she's most excited about in cancer research in 2019 – single-cell technologies.
NCRI's Chief Executive, Dr Iain Frame, shares his thoughts on the #NCRI2018 conference and what he's looking forward to in cancer research in 2019.
First-year PhD student, Nithya Paranthaman, shares her thoughts on studying at the ICR for her PhD and how she has found London since moving here from America.
Professor Nick Turner discusses the latest results from a phase III clinical trial (Paloma-3) of the drug the findings strengthen the case for making palbociclib available to women whose cancer has progressed on prior hormone therapy.
Here in London, our scientists conduct world-leading research every day. Our mission? To defeat cancer.